JP2020516647A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020516647A5 JP2020516647A5 JP2019555854A JP2019555854A JP2020516647A5 JP 2020516647 A5 JP2020516647 A5 JP 2020516647A5 JP 2019555854 A JP2019555854 A JP 2019555854A JP 2019555854 A JP2019555854 A JP 2019555854A JP 2020516647 A5 JP2020516647 A5 JP 2020516647A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- amino acid
- acid sequence
- seq
- tslp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023080295A JP2023099233A (ja) | 2017-04-12 | 2023-05-15 | 抗ｔｓｌｐ抗体による喘息治療 |
| JP2024127900A JP2024150751A (ja) | 2017-04-12 | 2024-08-02 | 抗ｔｓｌｐ抗体による喘息治療 |
| JP2025147176A JP2025170430A (ja) | 2017-04-12 | 2025-09-04 | 抗ｔｓｌｐ抗体による喘息治療 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762484864P | 2017-04-12 | 2017-04-12 | |
| US62/484,864 | 2017-04-12 | ||
| US201762553477P | 2017-09-01 | 2017-09-01 | |
| US201762553575P | 2017-09-01 | 2017-09-01 | |
| US62/553,477 | 2017-09-01 | ||
| US62/553,575 | 2017-09-01 | ||
| PCT/US2018/027271 WO2018191479A1 (en) | 2017-04-12 | 2018-04-12 | Treatment of asthma with anti-tslp antibody |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023080295A Division JP2023099233A (ja) | 2017-04-12 | 2023-05-15 | 抗ｔｓｌｐ抗体による喘息治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020516647A JP2020516647A (ja) | 2020-06-11 |
| JP2020516647A5 true JP2020516647A5 (https=) | 2022-11-22 |
| JP7330896B2 JP7330896B2 (ja) | 2023-08-22 |
Family
ID=62092313
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019555854A Active JP7330896B2 (ja) | 2017-04-12 | 2018-04-12 | 抗ｔｓｌｐ抗体による喘息治療 |
| JP2023080295A Withdrawn JP2023099233A (ja) | 2017-04-12 | 2023-05-15 | 抗ｔｓｌｐ抗体による喘息治療 |
| JP2024127900A Pending JP2024150751A (ja) | 2017-04-12 | 2024-08-02 | 抗ｔｓｌｐ抗体による喘息治療 |
| JP2025147176A Pending JP2025170430A (ja) | 2017-04-12 | 2025-09-04 | 抗ｔｓｌｐ抗体による喘息治療 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023080295A Withdrawn JP2023099233A (ja) | 2017-04-12 | 2023-05-15 | 抗ｔｓｌｐ抗体による喘息治療 |
| JP2024127900A Pending JP2024150751A (ja) | 2017-04-12 | 2024-08-02 | 抗ｔｓｌｐ抗体による喘息治療 |
| JP2025147176A Pending JP2025170430A (ja) | 2017-04-12 | 2025-09-04 | 抗ｔｓｌｐ抗体による喘息治療 |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US10828365B2 (https=) |
| EP (1) | EP3609917A1 (https=) |
| JP (4) | JP7330896B2 (https=) |
| KR (2) | KR102666879B1 (https=) |
| CN (1) | CN110573525A (https=) |
| AU (2) | AU2018253118B2 (https=) |
| BR (1) | BR112019021482A2 (https=) |
| CA (1) | CA3059364A1 (https=) |
| CL (1) | CL2019002897A1 (https=) |
| CO (1) | CO2019011462A2 (https=) |
| IL (1) | IL269791B (https=) |
| JO (1) | JOP20190243B1 (https=) |
| MX (1) | MX2019012158A (https=) |
| MY (1) | MY207509A (https=) |
| PE (1) | PE20200484A1 (https=) |
| PH (1) | PH12019502331A1 (https=) |
| SG (1) | SG11201909322VA (https=) |
| TN (1) | TN2019000289A1 (https=) |
| TW (2) | TW202523688A (https=) |
| UA (1) | UA130334C2 (https=) |
| UY (1) | UY37676A (https=) |
| WO (1) | WO2018191479A1 (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20210650T1 (hr) * | 2015-09-09 | 2021-05-28 | Novartis Ag | Protutijela koja vežu timusni stromalni limfopoetin (tslp) i postupci uporabe protutijela |
| KR102666879B1 (ko) * | 2017-04-12 | 2024-05-23 | 암젠 인크 | 항-tslp 항체를 이용한 천식의 치료 |
| JP7628966B2 (ja) | 2019-06-04 | 2025-02-12 | ジエンス ヘンルイ メデイシンカンパニー リミテッド | 胸線間質性リンパ球増殖因子に結合可能な抗体およびその使用 |
| CA3147044A1 (en) * | 2019-07-11 | 2021-01-14 | Tavotek Biotherapeutics (Hong Kong) Limited | Agents that interfere with thymic stromal lymphopoietin (tslp)-receptor signaling |
| EP4025602A4 (en) * | 2019-09-04 | 2023-12-13 | Biosion, Inc. | TSLP BINDING ANTIBODIES AND USES THEREOF |
| PH12022551022A1 (en) * | 2019-10-28 | 2023-03-06 | Medimmune Ltd | Dry powder formulations of thymic stromal lymphopoietin (tslp)-binding antibodies and methods of use thereof |
| CN114887053B (zh) * | 2019-11-29 | 2026-04-24 | 康诺亚生物医药科技（成都）有限公司 | 一种tslp相关病症治疗剂的开发和应用 |
| AU2020400221A1 (en) * | 2019-12-13 | 2022-05-19 | Harbour Biomed (Shanghai) Co., Ltd. | Anti-TSLP antibody and uses thereof |
| TW202140550A (zh) | 2020-01-29 | 2021-11-01 | 瑞士商諾華公司 | 使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法 |
| EP4103605A1 (en) * | 2020-02-13 | 2022-12-21 | Amgen Inc. | Treatment of atopic dermatitis with anti-tslp antibody |
| MX2022010012A (es) * | 2020-02-13 | 2022-09-07 | Amgen Inc | Formulaciones de anticuerpos anti-tslp humanos y métodos de tratamiento de una enfermedad inflamatoria. |
| IL295511A (en) * | 2020-02-18 | 2022-10-01 | Amgen Inc | Formulations of human anti-tslp antibodies and methods of using them |
| CN113388035B (zh) * | 2020-03-13 | 2026-02-27 | 迈威(上海)生物科技股份有限公司 | 特异性针对人tslp的抗体及其应用 |
| WO2022117079A1 (zh) * | 2020-12-03 | 2022-06-09 | 江苏恒瑞医药股份有限公司 | 结合胸腺基质淋巴细胞生成素的抗体及其应用 |
| CN113501878B (zh) * | 2021-02-03 | 2022-12-02 | 北京智仁美博生物科技有限公司 | 针对人tslp的多种抗体及其用途 |
| CN114853888B (zh) * | 2021-02-05 | 2023-11-03 | 上海洛启生物医药技术有限公司 | 抗tslp纳米抗体及其应用 |
| EP4302778A4 (en) * | 2021-03-03 | 2025-03-12 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | PHARMACEUTICAL COMPOSITION CONTAINING AN ANTI-TSLP ANTIBODY |
| PH12023552762A1 (en) * | 2021-04-19 | 2024-04-15 | Medimmune Ltd | An anti-tslp fab with improved stability |
| KR20230175245A (ko) | 2021-04-23 | 2023-12-29 | 암젠 인크 | 변형된 항-tslp 항체 |
| EP4326766A1 (en) * | 2021-04-23 | 2024-02-28 | Amgen Inc. | Anti-tslp antibody compositions and uses thereof |
| CN113683694B (zh) * | 2021-09-03 | 2022-05-13 | 江苏荃信生物医药股份有限公司 | 一种抗人tslp单克隆抗体及其应用 |
| CN117209603B (zh) * | 2021-12-02 | 2024-02-27 | 北京东方百泰生物科技股份有限公司 | 一种抗tslp的单克隆抗体、其抗原结合片段及其应用 |
| CN117327176A (zh) * | 2022-06-24 | 2024-01-02 | 南京融捷康生物科技有限公司 | 一种抗tslp的单域抗体及其用途 |
| US12110324B2 (en) | 2022-07-22 | 2024-10-08 | Flagship Pioneering Innovations Vi, Llc | Antigen binding molecules targeting thymic stromal lymphopoietin (TSLP) |
| TW202426485A (zh) | 2022-10-26 | 2024-07-01 | 美商安進公司 | 抗ｔｓｌｐ抗體組成物及其用途 |
| WO2025049343A1 (en) * | 2023-08-25 | 2025-03-06 | Proteologix Us Inc. | Anti-tslp antibody constructs and uses thereof |
| AU2024334289A1 (en) | 2023-08-25 | 2026-04-09 | Proteologix Us Inc. | Anti-il-13 multispecific antibody constructs and uses thereof |
| CN117551195B (zh) * | 2024-01-12 | 2024-04-09 | 杭州畅溪制药有限公司 | 靶向tslp的vhh纳米抗体及其应用 |
| WO2025179220A1 (en) * | 2024-02-22 | 2025-08-28 | Flagship Pioneering Innovations Vi, Llc | Dosing of antigen binding molecules targeting thymic stromal lymphopoietin (tslp) |
| WO2025264860A2 (en) | 2024-06-18 | 2025-12-26 | Yale University | Methods of treating post-covid airway disease |
| US20260098100A1 (en) * | 2024-10-04 | 2026-04-09 | Prana Therapies, Inc. | Il-4r and tslp inhibitors and methods of use thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DE69120146T2 (de) | 1990-01-12 | 1996-12-12 | Cell Genesys Inc | Erzeugung xenogener antikörper |
| WO1996033735A1 (en) | 1995-04-27 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| ATE158021T1 (de) | 1990-08-29 | 1997-09-15 | Genpharm Int | Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper |
| ES2301158T3 (es) | 1992-07-24 | 2008-06-16 | Amgen Fremont Inc. | Produccion de anticuerpos xenogenicos. |
| US7982016B2 (en) * | 2007-09-10 | 2011-07-19 | Amgen Inc. | Antigen binding proteins capable of binding thymic stromal lymphopoietin |
| US8359965B2 (en) | 2007-09-17 | 2013-01-29 | Oxford J Craig | Apparatus and method for broad spectrum radiation attenuation |
| UY32038A (es) | 2008-08-08 | 2010-03-26 | Glaxo Wellcome Mfg Pte Ltd | Inmunoblobulinas anti-cd127 y sus usos |
| ES2784123T3 (es) | 2009-11-04 | 2020-09-22 | Merck Sharp & Dohme | Anticuerpo anti TSLP genomodificado |
| WO2012007495A1 (en) | 2010-07-15 | 2012-01-19 | F. Hoffmann-La Roche Ag | Antibodies specifically binding to human tslpr and methods of use |
| US9100245B1 (en) | 2012-02-08 | 2015-08-04 | Amazon Technologies, Inc. | Identifying protected media files |
| US9306926B2 (en) | 2013-03-15 | 2016-04-05 | Brian A. Truong | User authentication using unique hidden identifiers |
| AR098155A1 (es) * | 2013-10-23 | 2016-05-04 | Genentech Inc | Métodos para diagnosticar y tratar trastornos eosinofílicos |
| CA2955086A1 (en) * | 2014-08-08 | 2016-02-11 | Alector Llc | Anti-trem2 antibodies and methods of use thereof |
| KR20170123315A (ko) * | 2015-03-11 | 2017-11-07 | 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 | Tslp 결합 단백질 |
| EA038332B1 (ru) | 2015-09-09 | 2021-08-10 | Новартис Аг | Молекулы, связывающиеся с тимусным стромальным лимфопоэтином (tslp), и способы применения таких молекул |
| KR102666879B1 (ko) * | 2017-04-12 | 2024-05-23 | 암젠 인크 | 항-tslp 항체를 이용한 천식의 치료 |
-
2018
- 2018-04-12 KR KR1020197033043A patent/KR102666879B1/ko active Active
- 2018-04-12 US US15/951,602 patent/US10828365B2/en active Active
- 2018-04-12 BR BR112019021482-8A patent/BR112019021482A2/pt unknown
- 2018-04-12 TN TNP/2019/000289A patent/TN2019000289A1/en unknown
- 2018-04-12 JO JOJO/P/2019/0243A patent/JOP20190243B1/ar active
- 2018-04-12 MX MX2019012158A patent/MX2019012158A/es unknown
- 2018-04-12 EP EP18721605.6A patent/EP3609917A1/en active Pending
- 2018-04-12 AU AU2018253118A patent/AU2018253118B2/en active Active
- 2018-04-12 JP JP2019555854A patent/JP7330896B2/ja active Active
- 2018-04-12 MY MYPI2019005927A patent/MY207509A/en unknown
- 2018-04-12 IL IL269791A patent/IL269791B/en unknown
- 2018-04-12 PE PE2019002026A patent/PE20200484A1/es unknown
- 2018-04-12 CN CN201880026131.3A patent/CN110573525A/zh active Pending
- 2018-04-12 UY UY0001037676A patent/UY37676A/es not_active Application Discontinuation
- 2018-04-12 SG SG11201909322V patent/SG11201909322VA/en unknown
- 2018-04-12 TW TW113133318A patent/TW202523688A/zh unknown
- 2018-04-12 WO PCT/US2018/027271 patent/WO2018191479A1/en not_active Ceased
- 2018-04-12 CA CA3059364A patent/CA3059364A1/en active Pending
- 2018-04-12 TW TW107112622A patent/TWI856945B/zh active
- 2018-04-12 UA UAA201911056A patent/UA130334C2/uk unknown
- 2018-04-12 KR KR1020247015858A patent/KR20240070727A/ko active Pending
-
2019
- 2019-10-11 PH PH12019502331A patent/PH12019502331A1/en unknown
- 2019-10-11 CL CL2019002897A patent/CL2019002897A1/es unknown
- 2019-10-16 CO CO2019011462A patent/CO2019011462A2/es unknown
-
2020
- 2020-11-09 US US17/093,387 patent/US20210052726A1/en not_active Abandoned
-
2023
- 2023-05-15 JP JP2023080295A patent/JP2023099233A/ja not_active Withdrawn
-
2024
- 2024-08-02 JP JP2024127900A patent/JP2024150751A/ja active Pending
- 2024-10-08 US US18/909,660 patent/US20250032608A1/en active Pending
-
2025
- 2025-06-24 AU AU2025204735A patent/AU2025204735A1/en active Pending
- 2025-09-04 JP JP2025147176A patent/JP2025170430A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020516647A5 (https=) | ||
| AU2018253118B2 (en) | Treatment of asthma with anti-TSLP antibody | |
| Md Yusof et al. | Targeting interleukin-6 in rheumatoid arthritis | |
| US20240287170A1 (en) | Methods for treating systemic sclerosis | |
| JP2025164767A (ja) | Ｉｌ－３３アンタゴニストを投与することによりｃｏｐｄを治療するための方法 | |
| KR20230084166A (ko) | Ox40 관련 질환을 치료하는 방법 | |
| JP2018533588A (ja) | 治療パラダイム | |
| TWI870471B (zh) | 全身性硬化症治療用醫藥組合物 | |
| JP2023506779A (ja) | 慢性移植片対宿主病の処置用抗体 | |
| US20240425577A1 (en) | Pan-elr+ cxc chemokine antibodies for the treatment of hidradenitis suppurativa | |
| CN113993543B (zh) | 使用抗cd38抗体的组合疗法 | |
| TW201842933A (zh) | 使用il-17拮抗劑選擇性治療氣喘的方法 | |
| TW202206457A (zh) | 用於治療呼吸疾病之泛elr+ cxc趨化因子抗體 | |
| TWI886758B (zh) | 抗pvrig/抗tigit雙特異性抗體在治療惡性腫瘤中的用途 | |
| CN121889429A (zh) | 用于治疗嗜酸性肉芽肿性多血管炎的IL-5R-α抗体 | |
| CA3117142C (en) | Pan-elr+ cxc chemokine antibodies for the treatment of hidradenitis suppurativa | |
| AU2024344855A1 (en) | Il-5r-alpha antibodies for treating eosinophilic granulomatosis with polyangiitis | |
| JP2025538208A (ja) | 抗ｃｔｌａ４抗体を使用して膵臓癌を治療する方法 | |
| CN119923276A (zh) | 用于治疗患有中度至重度系统性红斑狼疮的患者的抗cd38抗体的皮下给药 | |
| HK40127073A (zh) | 使用抗ctla4抗体治疗胰腺癌的方法 | |
| WO2025120567A1 (en) | Method of treatment of asthma | |
| CN121909045A (zh) | 一种重组抗IL-23p19抗体治疗中重度银屑病的方法 | |
| CN120513100A (zh) | 一种tslp抗体治疗哮喘的方法 | |
| HK40127979A (zh) | 治疗系统性硬化症的方法 | |
| CN115531531A (zh) | 抗人vegf抗体和化疗联用在制备治疗结直肠癌药物中的用途 |